Pfanstiehl Establishes Asian Subsidary
November 30, 2015
Pfanstiehl, a leading US-based manufacturer of cGMP high purity, low endotoxin injectable grade excipients and biopharmaceutical components for upstream bioprocessing, downstream formulation, and specialty applications, has announced the establishment of its Asian subsidiary, Pfanstiehl Singapore Pte. Ltd. The subsidiary will be anchored in Singapore, but will provide the foundation to support Pfanstiehl’s growing customer base throughout the Asia-Pacific region.
Pfanstiehl Singapore will offer the same tried and true, platform-enabling protein stabilizers, lyoprotectants, cell culture media components, and solubilizers as Pfanstiehl, Inc. Such technologies include Trehalose, Sucrose, Mannitol, Sorbitol, Maltose, Galactose, Mannose, and Cyclodextrins.
Pfanstiehl Singapore Pte. Ltd.
28 Bukit Pasoh Road
+65 6602 8180